Global Biosimulation Market Growth, Trends & Forecasts 2017 - 2022

  • ID: 4387643
  • Report
  • Region: Global
  • 185 pages
  • Mordor Intelligence
1 of 4
The global market for biosimulation is expected to reach USD 1.88 billion by the end of 2020, growing at a CAGR of around 17.3% from 2014 to 2021.

The simulating of biological process with the help of computer-aided mathematical program is called biosimulation. Biosimulation provides a systematic approach for integrating the clinical and biological data into functional metabolic pathways. The applications of biosimulation include obtaining a quantitative understanding of the regulation of blood levels and glucose simulated insulin secretion in order to investigate the role that the various physiological processes play in diabetes and others. The areas of future research in biosimulation include obtaining a better understanding of disease heterogeneity and the biological changes that occur during disease progression to predict the effects of various therapeutic approaches on different categories of people.

Global Biosimulation Market-Market Dynamics

The report details several factors driving and restraining the market. Some of these are listed below.

Drivers

Some of the factors contributing to the growth of the market are:

Need for advanced biosimulation tools

Failure of clinical trials

Increased spending on healthcare due to rise in per capita income

Rise in the level of accuracy of prediction before actual trial

Restraints

In spite of the scope for growth, there are some factors constraining the global market for biosimulation. These include:

Lack of awareness among healthcare professionals

Lack of standardized processes

Shortfall of skilled personnel to handle the software

North America is considered the largest market for biosimulation due to the availability of infrastructure. The global biosimulation market is segmented on the basis of applications into drug discovery (lead optimization, lead validation, target identification and target validation) and drug development (pre-clinical testing and clinical trials) and on the basis of the region into North America, Europe, Asia-Pacific and Rest of the World.

This Report Offers:
Market definition along with identification of key drivers and restraints for the market.

Market analysis for the biosimulation market, with region-specific assessments and competition analysis on a global and regional scale.

Identification of factors instrumental in changing the market scenario, rising prospective opportunities and identification of key companies that can influence the market on a global and regional scale.

Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market share.

Identification and analysis of the macro and micro factors that affect the biosimulation market on both global and regional scale.

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
READ MORE
Note: Product cover images may vary from those shown
2 of 4
1. Introduction
1.1 Report Description
1.2 Markets Covered
1.3 Research Methodology
2. Executive Summary
3. Market Overview
3.1 Market Definition
3.2 Market Drivers
3.2.1 Need for advanced biosimulation tools
3.2.2 Failure of clinical trials
3.2.3 Increased spending on healthcare due to rise in per capita income
3.2.4 Rise in the level of accuracy of prediction before actual trial
3.3 Market Restraints
3.3.1 Lack of awareness among healthcare professionals
3.3.2 Lack of standardized process
3.3.3 Shortfall of skilled personnel to handle the software
3.4 Market Opportunities
3.5 Market Threats
4. PorterFive Force Analysis
4.1 Bargaining Power of suppliers
4.2 Bargaining power of buyers
4.3 Degree of competition
4.4 Threat of substitution
4.5 Threat of new entrants
5. Market Segmentation
5.1 Global Biosimulation Market
5.1.1 By Applications
5.1.1.1 Drug Discovery
5.1.1.1.1 Lead Optimization
5.1.1.1.2 Lead Validation
5.1.1.1.3 Target Identification
5.1.1.1.4 Target Validation
5.1.1.2 Drug Development
5.1.1.2.1 Pre-Clinical Testing
5.1.1.2.2 Clinical Trials
5.1.2 By Geography
5.1.2.1 North America
5.1.2.1.1 USA
5.1.2.1.2 Canada
5.1.2.1.3 Mexico
5.1.2.2 Europe
5.1.2.2.1 UK
5.1.2.2.2 Germany
5.1.2.2.3 France
5.1.2.2.4 Italy
5.1.2.2.5 Spain
5.1.2.3 Asia-Pacific
5.1.2.3.1 China
5.1.2.3.2 Japan
5.1.2.3.3 India
5.1.2.3.4 Australia
5.1.2.4 RoW
6. Competitive Landscape
6.1 Mergers & Acquisitions
6.2 Agreements, Collaborations & Partnerships
6.3 New Product Launches
6.4 Recommendations to new market players
7. Company Profiles
7.1 Rhenovia Pharma
7.2 Accelrys
7.3 Certara
7.4 Genedata
7.5 Leadscope
7.6 Compugen
7.7 Archimedes

List of Tables

1: Global Biosimulation Market(USD million)(2017 - 2022).
2: Global Biosimulation Market-By Applications-(USD million)(2017 - 2022).
3: Global Biosimulation Market-By Applications-Drug Discovery-(USD million)(2017 - 2022).
4: Global Biosimulation Market-By Applications-Drug Discovery-Lead Optimization-(USD million)(2017 - 2022).
5: Global Biosimulation Market-By Applications-Drug Discovery-Lead Validation-(USD million)(2017 - 2022).
6: Global Biosimulation Market-By Applications-Drug Discovery-Target Identification-(USD million)(2017 - 2022).
7: Global Biosimulation Market-By Applications-Drug Discovery-Target Validation-(USD million)(2017 - 2022).
8: Global Biosimulation Market-By Applications-Drug Development-(USD million)(2017 - 2022).
9: Global Biosimulation Market-By Applications-Drug Development-Pre-Clinical Testing-(USD million)(2017 - 2022).
10: Global Biosimulation Market-By Applications-Drug Development-Clinical Trials-(USD million)(2017 - 2022).
11: North American Biosimulation Market(USD million)(2017 - 2022).
12: North American Biosimulation Market-By Applications-(USD million)(2017 - 2022).
13: North American Biosimulation Market-By Applications-Drug Discovery-(USD million)(2017 - 2022).
14: North American Biosimulation Market-By Applications-Drug Discovery-Lead Optimization-(USD million)(2017 - 2022).
15: North American Biosimulation Market-By Applications-Drug Discovery-Lead Validation-(USD million)(2017 - 2022).
16: North American Biosimulation Market-By Applications-Drug Discovery-Target Identification-(USD million)(2017 - 2022).
17: North American Biosimulation Market-By Applications-Drug Discovery-Target Validation-(USD million)(2017 - 2022).
18: North American Biosimulation Market-By Applications-Drug Development-(USD million)(2017 - 2022).
19: North American Biosimulation Market-By Applications-Drug Development-Pre-Clinical Testing-(USD million)(2017 - 2022).
20: North American Biosimulation Market-By Applications-Drug Development-Clinical Trials-(USD million)(2017 - 2022).
21: European Biosimulation Market(USD million)(2017 - 2022).
22: European Biosimulation Market-By Applications-(USD million)(2017 - 2022).
23: European Biosimulation Market-By Applications-Drug Discovery-(USD million)(2017 - 2022).
24: European Biosimulation Market-By Applications-Drug Discovery-Lead Optimization-(USD million)(2017 - 2022).
25: European Biosimulation Market-By Applications-Drug Discovery-Lead Validation-(USD million)(2017 - 2022).
26: European Biosimulation Market-By Applications-Drug Discovery-Target Identification-(USD million)(2017 - 2022).
27: European Biosimulation Market-By Applications-Drug Discovery-Target Validation-(USD million)(2017 - 2022).
28: European Biosimulation Market-By Applications-Drug Development-(USD million)(2017 - 2022).
29: European Biosimulation Market-By Applications-Drug Development-Pre-Clinical Testing-(USD million)(2017 - 2022).
30: European Biosimulation Market-By Applications-Drug Development-Clinical Trials-(USD million)(2017 - 2022).
31: Asia-Pacific Biosimulation Market(USD million)(2017 - 2022).
32: Asia-Pacific Biosimulation Market-By Applications-(USD million)(2017 - 2022).
33: Asia-Pacific Biosimulation Market-By Applications-Drug Discovery-(USD million)(2017 - 2022).
34: Asia-Pacific Biosimulation Market-By Applications-Drug Discovery-Lead Optimization-(USD million)(2017 - 2022).
35: Asia-Pacific Biosimulation Market-By Applications-Drug Discovery-Lead Validation-(USD million)(2017 - 2022).
36: Asia-Pacific Biosimulation Market-By Applications-Drug Discovery-Target Identification-(USD million)(2017 - 2022).
37: Asia-Pacific Biosimulation Market-By Applications-Drug Discovery-Target Validation-(USD million)(2017 - 2022).
38: Asia-Pacific Biosimulation Market-By Applications-Drug Development-(USD million)(2017 - 2022).
39: Asia-Pacific Biosimulation Market-By Applications-Drug Development-Pre-Clinical Testing-(USD million)(2017 - 2022).
40: Asia-Pacific Biosimulation Market-By Applications-Drug Development-Clinical Trials-(USD million)(2017 - 2022).
41: Rest of the World Biosimulation Market(USD million)(2017 - 2022).
42: Rest of the World Biosimulation Market-By Applications-(USD million)(2017 - 2022).
43: Rest of the World Biosimulation Market-By Applications-Drug Discovery-(USD million)(2017 - 2022).
44: Rest of the World Biosimulation Market-By Applications-Drug Discovery-Lead Optimization-(USD million)(2017 - 2022).
45: Rest of the World Biosimulation Market-By Applications-Drug Discovery-Lead Validation-(USD million)(2017 - 2022).
46: Rest of the World Biosimulation Market-By Applications-Drug Discovery-Target Identification-(USD million)(2017 - 2022).
47: Rest of the World Biosimulation Market-By Applications-Drug Discovery-Target Validation-(USD million)(2017 - 2022).
48: Rest of the World Biosimulation Market-By Applications-Drug Development-(USD million)(2017 - 2022).
49: Rest of the World Biosimulation Market-By Applications-Drug Development-Pre-Clinical Testing-(USD million)(2017 - 2022).
50: Rest of the World Biosimulation Market-By Applications-Drug Development-Clinical Trials-(USD million)(2017 - 2022).
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
Note: Product cover images may vary from those shown
Adroll
adroll